홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

콘드로이틴황산나트륨

Chondroitin Sulfate

HCID 24766
새 반응
인쇄

데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다

기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
24967-93-9
표준 SMILES
CC(=O)N[C@@H]1[C@@H](O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H](OS(=O)(=O)O)O[C@H]1O
InChIKey
KXKPYJOVDUMHGS-OSRGNVMNSA-N
분자식
C13H21NO15S
평균 분자량
463.37 g/mol
단동위원소 질량
463.06319014

개요

Chondroitin sulfate is a glycosaminoglycan considered as a symptomatic slow-acting drug for osteoarthritis (SYSADOA). The SYSADOA status suggested a pain relief and increased joint mobility after a relative long regular administration, as well as a long-lasting effect after the end of the treatment. Chondroitin sulfate is composed of alternating 1,3-N-acetyl-β-d-galactosamine and 1,4-β-d-glucuronic acid units which bear 4-O- and/or 6-O-sulfations at the N-acetylgalactosamine units disposed of in specific patterns. Depending on the predominating disaccharide unit, it will present different biological activities. Chondroitin sulfate is sold as an OTC dietary supplement in North America and it is a prescription drug under the EMA in Europe.

이름 및 식별자

우선 이름
Chondroitin Sulfate
IUPAC
(2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-sulfooxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
현지명
콘드로이틴황산나트륨
영어명
Chondroitin 4-sulfate
분자식
(C14H19NO14SNa2)n
분자량
499.38

이름 및 동의어

Chondroitin sulfate9007-28-7Chondroitin, hydrogen sulfateCHEBI:37397(2S,3S,4S,5R,6R)-6-{[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxy)oxan-4-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid(2S,3S,4S,5R,6R)-6-(((2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxy)oxan-4-yl)oxy)-3,4,5-trihydroxyoxane-2-carboxylic acidRefChem:7109DTXSID8031021Sodium chondroitin sulfate39455-18-0Chondroitine sulfateChondroitin 4-sulfate sodium salt
이름 더 보기
소듐콘드로이틴설페이트CHONDROITIN-4-SULFATECHONDROITIN SULFATE AturkadonChodroitin SulfatechondroitinasulfateChondroitinSulphateAchondroitinsulfatetypeaCSAChondroitin-4-sulfate
(2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-sulfooxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acidMFCD00146419CondrosulfChondroitinsulfate CC13H21NO15SChondroitin 4 and 6 sulfateChondronStructum

물성

구조 계산 물성보충 중

XLogP
-4.8
극성 표면적
267 Ų
수소 결합 공여자 수
8
수소 결합 수용자 수
15
회전 가능 결합 수
6
무거운 원자 수
30
형식 전하
0
복잡도
739

실험 및 물리화학적 성질

CosmeticsAntistatic; Hair conditioning
SolubilitySoluble
Melting Point190-194ºC
Dissociation Constants1.5-2

물리화학적 성질

저장 조건
2 · 2-8°C
용해도
2 O: · H2O: 0.1 g/mL, 약간 흐릿함, 희미한 노란색
화학적 성질 · 1건

White or yellowish amorphous powder. Tasteless, odorless, hygroscopic, soluble in water, insoluble in organic solvents such as ethanol, acetone, ether, etc. Optical rotation -25°-+35°(c=1, H2O). There are characteristic absorption peaks at 725cm-1, 852cm-1 and 930cm-1 by infrared spectroscopy.

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 5건

This chemical does not meet GHS hazard criteria for 63.6% (7 of 11) of all reports.

Danger

H317 (36.4%): May cause an allergic skin reaction [Warning Sensitization, Skin]

P233, P260, P261, P271, P272, P280, P284, P302+P352, P304+P340, P317, P321, P333+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 11 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Regulatory Information · 4건

Chemical: Chondroitin, hydrogen sulfate

XU - indicates a substance exempt from reporting under the Chemical Data Reporting Rule, (40 CFR 711).

Chondroitin, hydrogen sulfate, sodium salt: Does not have an individual approval but may be used under an appropriate group standard

Chondroitin hydrogen sulfate: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Chondroitin, hydrogen sulfate: Environment tier I assessment
Hazard Classes and CategoriesSkin Sens. 1 (36.4%)

안전 데이터

wgk
3
독성
mouse,LD,oral,> 15gm/kg (15000mg/kg),Zhonghua Yixue Zazhi. Chinese Medical Journal. Vol. 58, Pg. 739, 1978.
F 고인화성물질
3-10

화학 및 산업

약리 정보

ATC Code · 2건

M - Musculo-skeletal system

QM - Musculo-skeletal system

Protein BindingChondroitin sulfate protein binding reports have shown a very low percentage of protein binding of only 0.23% of the total protein.
Pharmacodynamics · 1건

In clinical trials, chondroitin sulfate has been reported a significant pain relief. Some reports have shown no slow in joint damage. The effects of chondroitin sulfate have been very controversial. One of the characteristics of chondroitin is a slow onset of action with a maximal effect attained after several months. Chondroitin sulfate has been reported to have anti-inflammatory properties by reducing the synovitis and prevent proinflammatory cytokine up-regulation in arthritis models. It is also registered an anabolic effect of chondroitin sulfate in which it induces the synthesis of hyaluronate in synovial cells, it increases type II collagen and proteoglycan synthesis.

Mechanism of Action · 1건

Chondroitin sulfate functions as a major component of the intricate extracellular matrix. It is proposed that chondroitin sulfate supply can provide new building blocks for the synthesis of new matrix components. The anti-inflammatory effect of chondroitin sulfate is thought to be caused by the inhibition of the synthesis of inflammatory intermediates such as the inhibition of nitric oxide synthase, COX-2, microsomal prostaglandin synthase 1 and prostaglandin E2. It is reported also an inhibitory activity in the toll-like receptor 4 which will later inhibit inflammatory cytokines, NFkB and MyD88. This activity suggests a modulation of the MAP kinase pathway. On the other hand, some reports have pointed out an induction on the PKC/PI3K/Akt pathway in neuroblastoma. The anabolic effect of chondroitin sulfate is suggested to be caused by the inhibition of metalloproteinases such as MMP-1, -3 and -13 as well as ADAMTS-4 and -5.

Biological Half-Life · 1건

The approximate half-life of chondroitin sulfate and its derivative metabolites is 15 hours. After intramuscular administration of chondroitin sulfate in humans, the elimination half-life of the chondroitin sulfate was of 275 min. When administered orally, the elimination half-life was presented at 310 min.

관련 반응

5건
반응 기록 만들기
HRID 1003920 반응식
HRID 1003920반응물로
HRID 1095260 반응식
HRID 1095260반응물로
HRID 1714702 반응식
HRID 1714702반응물로
HRID 1816867 반응식
HRID 1816867반응물로
HRID 2239213 반응식
HRID 2239213반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트

데이터베이스 식별자

CAS
24967-93-9、25322-46-7、39455-18-0、9007-28-7、9082-07-9
PubChem CID
24766
DTXSID
DTXSID601017238
ChEMBL
CHEMBL2303614、CHEMBL5266347
EC Number
232-696-9
Metabolism/Metabolites · 1건

Chondroitin sulfate is not metabolized by cytochrome P450. Reports have indicated the presence in plasma of mono-, oligo- and polysaccharides with a molecular weight of less of 5 kDa which are derived from the partial digestion of exogenous chondroitin sulfate. The reported degradation of chondroitin sulfate seems to be very complex and led by the formation of smaller digestion derivatives of the original form.

Absorption, Distribution and Excretion · 3건

Chondroitin sulfate is absorbed from the gastrointestinal tract. The absorbed portion reaches a ratio of 10% as unchanged chondroitin sulfate and 90% as depolymerized low-molecular-weight derivatives. This absorption depends on the sulfation status. The bioavailability of chondroitin sulfate ranges from 10-20% following oral administration. Reports have shown a consistent accumulation of the compound in joint tissue. The steady-state is attained after 3-4 days and it takes around 3-6 months to obtain the maximal effect. After intramuscular administration of chondroitin sulfate, the peak plasma level of 3.8 mcg/ml was reached after 90 min. When given orally, the peak plasma concentration of 4.6 mcg/ml was reached after 240 min.

Chondroitin sulfate is excreted in the urine as intact polymers and as partial degradation products. After intramuscular administration, about 37% of the administered dose is excreted by urine during the first 24 hours as high- and low-molecular-weight derivatives.

After intramuscular administration of chondroitin sulfate, the apparent volume of distribution was 0.40 ml/g. When administered orally, the apparent volume of distribution changed to 0.44ml/g.

용도 및 제조

Household ProductsInformation on 4 consumer products that contain Sodium chondroitin sulfate in the following categories is provided:
Use ClassificationCosmetics -> Antistatic; Hair conditioning
General Manufacturing InformationChondroitin, hydrogen sulfate: ACTIVE
응용 분야 · 2건

개요Chondroitin 4-sulfate is a natural polymer of a disaccharide consisting of glucuronic acid and N-acetyl glucosamine which is sulfated either in the 4 or 6 position. It is a glycosaminoglycan considered as a symptomatic slow-acting drug for osteoarthritis (SYSADOA).

용도sodium chondroitin sulfate is described as a skin-conditioning agent, with possible anti-inflammatory properties. It can be found in such products as moisturizers and night skin care preparations. It is a derivative of natural mucopolysaccharides. Chondroitin 4-sulfate is an important structural component of cartilage and has been used as a dietary supplement to treat symptoms of joint discomfort.

상·하류 제품 정보

상류 원료

Strong acid styrene cation exchange resinΑ-protein판크레아틴

추가 설명

정의ChEBI: Chondroitin 4'-sulfate is a chondroitin sulfate in which the site of sulfation is carbon 4 of the N-acetylgalactosamine (GalNAc) sugar. It has a role as a mouse metabolite. It is a conjugate acid of a chondroitin 4'-sulfate anion.